Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/58072
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWang X.en
dc.contributor.authorAnderson C.en
dc.contributor.authorQureshi A.I.en
dc.contributor.authorSong L.en
dc.contributor.authorChalmers J.P.en
dc.contributor.authorPontes-Neto O.M.en
dc.contributor.authorMartins S.C.en
dc.contributor.authorVenturelli P.M.en
dc.contributor.authorLiu L.en
dc.contributor.authorYou C.en
dc.contributor.authorHu X.en
dc.contributor.authorMa L.en
dc.contributor.authorMa H.H.en
dc.contributor.authorRen X.en
dc.contributor.authorPhan T.G.en
dc.contributor.authorArima H.en
dc.contributor.authorRobinson T.G.en
dc.contributor.authorWang J.en
dc.contributor.authorChen X.en
dc.contributor.authorDelcourt C.en
dc.contributor.authorOuyang M.en
dc.contributor.authorLi Q.en
dc.date.accessioned2026-04-26T23:40:44Z-
dc.date.available2026-04-26T23:40:44Z-
dc.date.copyright2026-
dc.date.issued2026-04-10en
dc.identifier.citationNeurology. (no pagination), 2026. Article Number: e214671. Date of Publication: 2026.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/58072-
dc.description.abstractBackground and Objectives - While moderate and rapid systolic blood pressure (SBP) lowering was associated with better functional outcomes after intracerebral hemorrhage (ICH), large reductions in SBP within 1 hour, for example, reductions from >200 to <140 mm Hg, diminished or even reversed these beneficial effects. We aimed to define the optimal trajectory of SBP control in relation to favorable functional outcomes after acute ICH.Methods - We conducted a pooled analysis of individual patient-level data from all 4 Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT) and second Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II) trials, which were international, randomized, open-label, blinded, end point-assessed, controlled trials that determined the effectiveness of early intensive SBP control in acute ICH. Latent class analysis grouped SBP trajectories over the first 24 hours (9 measurements) into defined clusters. The primary outcome was functional recovery at 90 days after randomization, defined as modified Rankin Scale (mRS) scores of 3-6. Logistic regression models with adjustment for baseline covariates and trial were used to determine associations between SBP cluster trajectories and outcomes in INTERACT, with validation in ATACH-II.Results - A total of 11, 269 patients (INTERACT n = 10, 269; ATACH-II n = 1, 000; mean age 62.4 years; female 36.4%) with at least 1 postrandomization SBP reading were included. Six SBP trajectories were identified: low, moderate-to-low, moderate, high, high-to-moderate, and high-to-low. Compared with the low SBP group, associations with poor functional outcome (mRS scores 3-6) increased progressively across other groups in INTERACT (p = 0.04 for trend). Adjusted odds ratios (95% CI) for groups 2 to 6 were 1.16 (0.98-1.37), 1.44 (1.18-1.75), 1.46 (1.15-1.87), 1.90 (1.32-2.73), and 1.28 (1.02-1.60), respectively. A similar albeit nonsignificant trend was observed in ATACH-II due to limited power.Discussion - Distinct SBP trajectories over 24 hours defined prognosis after ICH, with a severe hypertensive group having the highest odds of death or disability, regardless of the BP-lowering strategy used. These findings highlight the importance of well-controlled but tailored SBP management strategies after ICH.Classification of Evidence - This study provides Class III evidence that distinct SBP trajectories over 24 hours are associated with prognosis after acute ICH, with a severe hypertensive group having the highest odds of poor functional outcome, regardless of the BP-lowering strategy used.Trial Registration Information - (INTERACT1 NCT00226096; INTERACT2 NCT00716079; INTERACT3 NCT03209258; INTERACT4 NCT03790800; ATACH-2 NCT01176565).Copyright © 2026 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.-
dc.publisherLippincott Williams and Wilkins-
dc.relation.ispartofNeurology-
dc.titleSystolic Blood Pressure Trajectory and Outcomes in Acute Intracerebral Hemorrhage: Pooled Analysis of the 4 INTERACT and ATACH-II Clinical Trials.-
dc.typeArticle In Press-
dc.identifier.affiliationNeurology-
dc.identifier.doihttps://dx.doi.org/10.1212/WNL.0000000000214671-
dc.publisher.placeUnited States-
dc.identifier.pubmedid41855454-
dc.identifier.institution(Delcourt) Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australiaen
dc.identifier.institution(Ma) Department of Neurology, Monash Health, Melbourne, Australiaen
dc.identifier.institution(Phan) Stroke & Aging Research Group, Monash University, Melbourne, Australiaen
dc.identifier.institution(Wang, Ren, Li, Ouyang, Delcourt, Chen, Liu, Chalmers, Song, Anderson) The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australiaen
dc.identifier.institution(Venturelli) Clinica Alemana de Santiago, Facultad de Medicina, Clinica Alemana Universidad del Desarrollo, Santiago, Chileen
dc.identifier.institution(Venturelli) Centro de Estudios Clinicos, Instituto de Ciencias e Innovacion en Medicina, Facultad de Medicina, Clinica Alemana Universidad del Desarrollo, Santiago, Chileen
dc.identifier.institution(Martins) Neurology Department, Hospital Moinhos de Vento, Porto Alegre, Brazilen
dc.identifier.institution(Pontes-Neto) Department of Neurology, Ribeirao Preto Medical School, University of Sao Paulo, Brazilen
dc.identifier.institution(Song, Anderson) Institute for Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, Chinaen
dc.identifier.institution(Anderson) Neurology Department, Royal Prince Alfred Hospital, Sydney, Australiaen
dc.identifier.institution(Liu) Centre for Big Data Research in Health, Faculty of Medicine, University of New South Wales, Sydney, Australiaen
dc.identifier.institution(Ma, Hu, You) Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Chinaen
dc.identifier.institution(Arima) Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Japanen
dc.identifier.institution(Robinson, Qureshi) Department of Cardiovascular Sciences, University of Leicester, United Kingdomen
dc.identifier.institution(Robinson) Department of Cardiovascular Sciences and NIHR Biomedical Research Unit in Cardiovascular Disease, University of Leicester, United Kingdomen
dc.identifier.institution(Wang) Centre for Epidemiological Studies and Clinical Trials, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Chinaen
dc.identifier.affiliationmh(Phan) Stroke & Aging Research Group, Monash University, Melbourne, Australiaen
dc.identifier.affiliationmh(Ma) Department of Neurology, Monash Health, Melbourne, Australiaen
item.fulltextNo Fulltext-
item.openairetypeArticle In Press-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
Appears in Collections:Articles
Show simple item record

Page view(s)

40
checked on May 23, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.